Quick Takeaways
- Parag Saxena filed SCHEDULE 13D/A for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.001 par value (RVPH).
- Disclosed ownership: 12%.
- Date of event: 18 Dec 2024.
Quoteable Key Fact
"Parag Saxena disclosed 12% ownership in REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, $0.001 par value (RVPH) on 18 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vedanta Associates-R, LP | 4.1% | 1,967,768 | 0 | 1,967,768 | By: Vedanta Partners, LLC, the general partner ("GP") of Vedanta Associates-R, L.P. /s/ Parag Saxena | Parag Saxena/CEO of Vedanta Partners, LLC | 0001865703 |
| Vedanta Associates, L.P. | 6.9% | 3,408,401 | 0 | 3,408,401 | By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena | Parag Saxena/CEO of Vedanta Partners, LLC | 0001502222 |
| Beta Operators Fund, L.P. | 4.4% | 2,138,130 | 0 | 2,138,130 | By: Vedanta Associates, L.P., the GP of Beta Operators Fund, L.P. By: Vedanta Partners, LLC, the GP of Vedanta Associates, L.P. /s/ Parag Saxena | Parag Saxena/CEO of Vedanta Partners, LLC | 0001614642 |
| VEDANTA PARTNERS, LLC | 11% | 5,376,169 | 0 | 5,376,169 | /s/ Parag Saxena | Parag Saxena/CEO | 0001502216 |
| Parag Saxena | 12% | 6,268,906 | 892,737 | 5,376,169 | /s/ Parag Saxena | Parag Saxena/Individual | 0001015823 |